Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 551-560

  Taylor, Donald P ^a,b   Clark, Amanda ^b   Wheeler, Sarah ^b   Wells, Alan ^a,b  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial to mesenchymal transition; Hepatic microenvironment; Mesenchymal to epithelial reverting transition; Mesenchymal to epithelial transition; Metastatic dormancy; Metastatic emergence; Nonparenchymal cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; UVOMORULIN;

ARTICLE; BREAST METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL ISOLATION; CELL STRAIN MCF 7; CELL TRANSPORT; CLEARANCE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HEPATIC NONPARENCHYMAL CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL; LIVER PARENCHYMA; PHASE TRANSITION; PHENOTYPE; PRIORITY JOURNAL; SPINDLE CELL; STEM CELL NICHE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MCF-7 CELLS; NEOPLASM METASTASIS; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84899474783     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2875-0     Document Type: Article

References (31)

1. Demicheli R (2001) Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin Cancer Biol 11(4):297-306. doi:10.1006/scbi 2001.0385
2. Taylor DP, Wells JZ, Savol A, Chennubhotla C, Wells A (2013) Modeling boundary conditions for balanced proliferation in metastatic latency. Clin Cancer Res 19(5):1063-1070. doi:10.1158/1078-0432.CCR-12-3180
3. Aguirre-Ghiso JA (2006) The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle 5(16):1740-1743
4. Townson JL, Chambers AF (2006) Dormancy of solitary metastatic cells. Cell Cycle 5(16):1744-1750 (Pubitemid 44435316)
5. Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9:179. doi:10.1186/1476-4598-9-179
6. Gunasinghe NP, Wells A, Thompson EW, Hugo HJ (2012) Mesenchymal- epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev. doi:10.1007/s10555-012-9377-5
7. Yates CC, Shepard CR, Stolz DB, Wells A (2007) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96(8):1246-1252. doi:10.1038/sj.bjc.6603700 (Pubitemid 46625074)
8. Kassis J, Lauffenburger DA, Turner T, Wells A (2001) Tumor invasion as dysregulated cell motility. Semin Cancer Biol 11(2):105-117. doi:10.1006/scbi.2000.0362S1044-579X(00)90362-6
9. Kim NG, Koh E, Chen X, Gumbiner BM (2011) E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA 108(29):11930-11935. doi:10.1073/pnas.1103345108
10. Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A (2012) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron 5(1):19-28. doi:10.1007/s12307-011-0085-4
11. Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5(6):R217-R222. doi:10.1186/bcr651
12. Chao Y, Wu Q, Shepard C, Wells A (2012) Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin Exp Metastasis 29(1):39-50. doi:10.1007/s10585-011-9427-3
13. Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP (2011) Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 22(14):2423-2435. doi:10.1091/mbc.E11-04-0306
14. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, Morris VL, Groom AC, Chambers AF (2002) Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62(7):2162-2168 (Pubitemid 34408466)
15. Kmiec Z (2001) Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161:III-XIII, 1-151
16. Michalopoulos GK (2007) Liver regeneration. J Cell Physiol 213(2):286-300. doi:10.1002/jcp.21172
17. Taub R (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5(10):836-847. doi:10.1038/nrm1489nrm1489
18. Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle RL (1982) Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 42(11):4673-4682 (Pubitemid 13205972)
19. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V (1983) Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 43(6):2704-2711 (Pubitemid 13100536)
20. Matsumura T, Takesue M, Westerman KA, Okitsu T, Sakaguchi M, Fukazawa T, Totsugawa T, Noguchi H, Yamamoto S, Stolz DB, Tanaka N, Leboulch P, Kobayashi N (2004) Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT. Transplantation 77(9):1357-1365 (Pubitemid 38668427)
21. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Investig Dermatol 99(6):683-690 (Pubitemid 23002027)
22. Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA (2009) p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med 15(8):369-379. doi:10.1016/j.molmed.2009.06.005
23. Aguirre-Ghiso JA, Bragado P, Sosa MS (2013) Metastasis awakening: targeting dormant cancer. Nat Med 19(3):276-277. doi:10.1038/nm.3120
24. Ranganathan AC, Adam AP, Zhang L, Aguirre-Ghiso JA (2006) Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells? Cancer Biol Ther 5(7):729-735 (Pubitemid 44775124)
25. Gong X, Ming X, Deng P, Jiang Y (2010) Mechanisms regulating the nuclear translocation of p38 MAP kinase. J Cell Biochem 110(6):1420-1429. doi:10.1002/jcb.22675
26. Balkwill F (2006) TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25(3):409-416. doi:10.1007/s10555-006-9005-3
27. De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M (2004) Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18(9):1016-1018. doi:10.1096/fj.03-1110fje (Pubitemid 39561510)
28. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233-1241. doi:10.1056/ NEJMoa022152 (Pubitemid 35176242)
29. Rubio N, Espana L, Fernandez Y, Blanco J, Sierra A (2001) Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: a role in dormancy and organospecificity. Lab Investig 81(5):725-734 (Pubitemid 32466535)
30. Shepard CR, Kassis J, Whaley DL, Kim HG, Wells A (2007) PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene 26(21):3020-3026. doi:10.1038/sj.onc.1210115 (Pubitemid 46733649)
31. Davidson NE, Visvanathan K, Emens L (2003) New findings about endocrine therapy for breast cancer. Breast 12(6):368-372 (Pubitemid 38008645)